NYU LANGONE HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1841-01-01

Employees: 10K

Market Cap: -

Website: http://www.nyulangone.org

Clinical Trials

Locus-coeruleus Function in Normal Elderly and AD Risk

Not Applicable

Completed

Conditions: Alzheimer Disease

Interventions: Procedure: Nocturnal polysomnography (NPSG)
Procedure: Lumbar Puncture (LP)
Other: PET-MR measurement with a norepinephrine transporter (NET)-selective radiotracer (S,S)-[11C]Omethylreboxetine ([11C]MRB)
Behavioral: Psychomotor Vigilance Task (PVT)

First Posted Date: 2020-05-27

Last Posted Date: 2024-04-08

Lead Sponsor: NYU Langone Health

Target Recruit Count: 30

Registration Number: NCT04403165

Locations: 🇺🇸
NYU Grossman School of Medicine, New York, New York, United States
🇺🇸
Icahn School of Medicine Mount Sinai, New York, New York, United States

Knotless Suture in Revision Total Joint Arthroplasty

Not Applicable

Completed

Conditions: Arthroplasty

First Posted Date: 2020-05-27

Last Posted Date: 2024-04-17

Lead Sponsor: NYU Langone Health

Target Recruit Count: 81

Registration Number: NCT04403919

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Targeting Hyaluronan Accumulation Through Exercise in T2DM

Not Applicable

Active, not recruiting

Conditions: Type 2 Diabetes Mellitus

Interventions: Behavioral: 10-week exercise program on HA accumulation

First Posted Date: 2020-05-12

Last Posted Date: 2024-02-07

Lead Sponsor: NYU Langone Health

Target Recruit Count: 30

Registration Number: NCT04383314

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

School-Based Mental Health Effectiveness Study

Not Applicable

Active, not recruiting

Conditions: Child Development

Interventions: Behavioral: ParentCorps-Professional Development (PD)
Behavioral: T-Wellness

First Posted Date: 2020-05-12

Last Posted Date: 2023-10-31

Lead Sponsor: NYU Langone Health

Target Recruit Count: 2444

Registration Number: NCT04383327

Locations: 🇺🇬
Hoima School, Hoima, Uganda
🇺🇬
Kampala School, Kampala, Uganda

Geniculate Artery Embolization for Treatment of Osteoarthritis

Not Applicable

Active, not recruiting

Conditions: Osteoarthritis

Interventions: Procedure: Transcatheter arterial embolization
Device: Embozene™ Microspheres

First Posted Date: 2020-05-07

Last Posted Date: 2024-05-30

Lead Sponsor: NYU Langone Health

Target Recruit Count: 38

Registration Number: NCT04379700

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

CHOlesterol Lowering and Residual Risk in Type 2 Diabetes

Phase 4

Completed

Conditions: Type 2 Diabetes

Interventions: Drug: Statin
Drug: PCSK9 inhibitor
Drug: Ezetimibe 10mg

First Posted Date: 2020-04-30

Last Posted Date: 2024-10-17

Lead Sponsor: NYU Langone Health

Target Recruit Count: 151

Registration Number: NCT04369664

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Treating COVID-19 With Hydroxychloroquine (TEACH)

Phase 2

Terminated

Conditions: COVID-19

Interventions: Drug: Hydroxychloroquine (HCQ)

First Posted Date: 2020-04-30

Last Posted Date: 2022-04-22

Lead Sponsor: NYU Langone Health

Target Recruit Count: 128

Registration Number: NCT04369742

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States
🇺🇸
State University of New York (SUNY) Downstate Medical Center, Brooklyn, New York, United States

Cardiovascular Effects of COVID-19

Phase 2

Completed

Conditions: COVID-19

Interventions: Drug: AT-001

First Posted Date: 2020-04-28

Last Posted Date: 2021-09-16

Lead Sponsor: NYU Langone Health

Target Recruit Count: 81

Registration Number: NCT04365699

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Transcranial Near Infrared Radiation and Cerebral Blood Flow in Depression

Not Applicable

Completed

Conditions: Major Depressive Disorder

Interventions: Device: Transcranial Photobiomodulator
Device: Sham

First Posted Date: 2020-04-28

Last Posted Date: 2023-06-05

Lead Sponsor: NYU Langone Health

Target Recruit Count: 55

Registration Number: NCT04366258

Locations: 🇺🇸
Massachusetts General Hospital, Charlestown, Massachusetts, United States
🇺🇸
Nathan Kline Institute, Orangeburg, New York, United States
🇺🇸
New York University, New York, New York, United States

CONTAIN COVID-19: Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients

Phase 2

Completed

Conditions: Coronavirus Infection
COVID-19
Coronavirus

Interventions: Biological: Convalescent Plasma
Other: Saline solution

First Posted Date: 2020-04-28

Last Posted Date: 2023-01-26

Lead Sponsor: NYU Langone Health

Target Recruit Count: 941

Registration Number: NCT04364737

Locations: 🇺🇸
Medical College of Wisconsin / Froedtert Memorial Lutheran Hospital, Milwaukee, Wisconsin, United States
🇺🇸
University of Miami Hospital and Clinics, Miami, Florida, United States
🇺🇸
Aurora St. Luke's Medical Center, Milwaukee, Wisconsin, United States

and more 5 locations

Home Terms & Conditions Privacy Policy